LivaNova - Page title

Press Releases

Jan 17, 2019

New Studies in the U.S. and Europe Demonstrate LivaNova Perceval Valveā€™s Strong Performance and Economic Advantage in Aortic Disease Treatment

Recently published data reinforces the ability of Perceval to optimize the surgical approach to aortic valve replacement LONDON --(BUSINESS WIRE)--Jan. 17, 2019-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced the publication of three separate studies...Read More